ArticleBMC neurology2026
Cerebral venous sinus thrombosis secondary to relapsed minimal change disease: a case managed with endovascular thrombolysis.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCerebral venous sinus thrombosis (CVST) is a rare type of stroke characterized by the formation of blood clots within the dural venous sinuses which has a high mortality rate. Despite its potential severity, cerebral venous sinus thrombosis secondary to nephrotic syndrome remains rarely reported and under-recognized in clinical practice. CASE PRESENTATION: We described a 20-year-old male who presented with a relapse of minimal change disease, complicated by extensive CVST. On the basis of anticoagulant therapy, his neurological condition deteriorated rapidly, manifesting as altered mental consciousness, progressive limb weakness, and new-onset seizures. Given the failure of conventional medical management, endovascular therapy of catheter-directed thrombolysis was performed. The patient's neurological status improved dramatically within days.
conclusionsThis case demonstrates that cerebral venous sinus thrombosis should be considered in nephrotic syndrome patients presenting with even subtle or non-specific neurological symptoms. Patients with focal neurological deficits, altered mental status, new-onset seizures, or unusual headache should undergo prompt neurological evaluation and appropriate brain imaging, including computed tomography venography (CTV) or magnetic resonance venography (MRV) when CVST is suspected. In the specific setting of nephrotic syndrome, clinicians should maintain a heightened index of suspicion for CVST, even when initial neurological findings are subtle or non-specific. As illustrated by this case, early recognition and timely escalation to endovascular therapy can be life-saving when conventional anticoagulation fails to prevent neurological deterioration. Our patient achieved complete neurological recovery and sustained remission of nephrotic syndrome, underscoring the value of multidisciplinary collaboration and individualized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.